Does the media favor AMN or BAX?

In the previous week, AMN Healthcare Services had 17 more articles in the media than Baxter International. MarketBeat recorded 23 mentions for AMN Healthcare Services and 6 mentions for Baxter International. AMN Healthcare Services' average media sentiment score of 0.71 beat Baxter International's score of 0.49 indicating that AMN Healthcare Services is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment AMN Healthcare Services 8 Very Positive mention(s) 4 Positive mention(s) 7 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Baxter International 2 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media refer more to BAX or DVA?

In the previous week, DaVita had 25 more articles in the media than Baxter International. MarketBeat recorded 31 mentions for DaVita and 6 mentions for Baxter International. DaVita's average media sentiment score of 0.59 beat Baxter International's score of 0.49 indicating that DaVita is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Baxter International 2 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral DaVita 11 Very Positive mention(s) 1 Positive mention(s) 10 Neutral mention(s) 4 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor BAX or EW?

In the previous week, Edwards Lifesciences had 1 more articles in the media than Baxter International. MarketBeat recorded 7 mentions for Edwards Lifesciences and 6 mentions for Baxter International. Edwards Lifesciences' average media sentiment score of 1.33 beat Baxter International's score of 0.49 indicating that Edwards Lifesciences is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Baxter International 2 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Edwards Lifesciences 5 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor BDX or BAX?

In the previous week, Becton, Dickinson and Company had 26 more articles in the media than Baxter International. MarketBeat recorded 32 mentions for Becton, Dickinson and Company and 6 mentions for Baxter International. Becton, Dickinson and Company's average media sentiment score of 0.74 beat Baxter International's score of 0.49 indicating that Becton, Dickinson and Company is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Becton, Dickinson and Company 10 Very Positive mention(s) 2 Positive mention(s) 13 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Baxter International 2 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media prefer IDXX or BAX?

In the previous week, IDEXX Laboratories had 21 more articles in the media than Baxter International. MarketBeat recorded 27 mentions for IDEXX Laboratories and 6 mentions for Baxter International. IDEXX Laboratories' average media sentiment score of 0.95 beat Baxter International's score of 0.49 indicating that IDEXX Laboratories is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment IDEXX Laboratories 13 Very Positive mention(s) 3 Positive mention(s) 7 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Baxter International 2 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Baxter International (BAX) Competitors

$27.41 -0.14 (-0.50%)

As of 09:53 AM Eastern

Compare

BAX vs. AMN, DVA, EW, BDX, and IDXX

Should you buy Baxter International stock or one of its competitors? MarketBeat compares Baxter International with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Baxter International include AMN Healthcare Services (AMN), DaVita (DVA), Edwards Lifesciences (EW), Becton, Dickinson and Company (BDX), and IDEXX Laboratories (IDXX). These companies are all part of the "healthcare" sector.

How does Baxter International compare to AMN Healthcare Services?

AMN Healthcare Services (NYSE:AMN) and Baxter International (NYSE:BAX) are both healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, valuation, dividends, media sentiment, earnings, analyst recommendations, profitability and risk.

AMN Healthcare Services has a net margin of 3.06% compared to Baxter International's net margin of -9.27%. AMN Healthcare Services' return on equity of 19.92% beat Baxter International's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
AMN Healthcare Services	3.06%	19.92%	5.93%
Baxter International	-9.27%	16.57%	5.24%

In the previous week, AMN Healthcare Services had 17 more articles in the media than Baxter International. MarketBeat recorded 23 mentions for AMN Healthcare Services and 6 mentions for Baxter International. AMN Healthcare Services' average media sentiment score of 0.71 beat Baxter International's score of 0.49 indicating that AMN Healthcare Services is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
AMN Healthcare Services	8 Very Positive mention(s)	4 Positive mention(s)	7 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Baxter International	2 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

AMN Healthcare Services has higher earnings, but lower revenue than Baxter International. Baxter International is trading at a lower price-to-earnings ratio than AMN Healthcare Services, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
AMN Healthcare Services	$3.43B	0.41	-$95.70M	$2.68	13.41
Baxter International	$11.47B	1.24	-$957M	-$2.07	N/A

AMN Healthcare Services has a beta of 0.4, suggesting that its stock price is 60% less volatile than the broader market. Comparatively, Baxter International has a beta of 0.6, suggesting that its stock price is 40% less volatile than the broader market.

99.2% of AMN Healthcare Services shares are owned by institutional investors. Comparatively, 90.2% of Baxter International shares are owned by institutional investors. 1.1% of AMN Healthcare Services shares are owned by insiders. Comparatively, 0.2% of Baxter International shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

AMN Healthcare Services pays an annual dividend of $1.20 per share and has a dividend yield of 3.3%. Baxter International pays an annual dividend of $0.04 per share and has a dividend yield of 0.1%. AMN Healthcare Services pays out 44.8% of its earnings in the form of a dividend. Baxter International pays out -1.9% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

AMN Healthcare Services presently has a consensus target price of $30.86, suggesting a potential downside of 14.12%. Baxter International has a consensus target price of $22.45, suggesting a potential downside of 18.24%. Given AMN Healthcare Services' stronger consensus rating and higher possible upside, equities research analysts plainly believe AMN Healthcare Services is more favorable than Baxter International.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
AMN Healthcare Services	2 Sell rating(s)	3 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.22
Baxter International	3 Sell rating(s)	8 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	1.92

Summary

AMN Healthcare Services beats Baxter International on 14 of the 18 factors compared between the two stocks.

How does Baxter International compare to DaVita?

Baxter International (NYSE:BAX) and DaVita (NYSE:DVA) are both large-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, institutional ownership, risk, earnings, media sentiment, dividends and valuation.

Baxter International has a beta of 0.6, meaning that its share price is 40% less volatile than the broader market. Comparatively, DaVita has a beta of 0.88, meaning that its share price is 12% less volatile than the broader market.

DaVita has higher revenue and earnings than Baxter International. Baxter International is trading at a lower price-to-earnings ratio than DaVita, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Baxter International	$11.47B	1.24	-$957M	-$2.07	N/A
DaVita	$13.64B	0.86	$746.80M	$12.22	15.01

90.2% of Baxter International shares are held by institutional investors. Comparatively, 90.1% of DaVita shares are held by institutional investors. 0.2% of Baxter International shares are held by company insiders. Comparatively, 1.9% of DaVita shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

DaVita has a net margin of 6.05% compared to Baxter International's net margin of -9.27%. Baxter International's return on equity of 16.57% beat DaVita's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Baxter International	-9.27%	16.57%	5.24%
DaVita	6.05%	-217.63%	5.07%

Baxter International currently has a consensus target price of $22.45, indicating a potential downside of 18.24%. DaVita has a consensus target price of $221.75, indicating a potential upside of 20.92%. Given DaVita's stronger consensus rating and higher probable upside, analysts plainly believe DaVita is more favorable than Baxter International.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Baxter International	3 Sell rating(s)	8 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	1.92
DaVita	1 Sell rating(s)	3 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.38

In the previous week, DaVita had 25 more articles in the media than Baxter International. MarketBeat recorded 31 mentions for DaVita and 6 mentions for Baxter International. DaVita's average media sentiment score of 0.59 beat Baxter International's score of 0.49 indicating that DaVita is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Baxter International	2 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
DaVita	11 Very Positive mention(s)	1 Positive mention(s)	10 Neutral mention(s)	4 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

DaVita beats Baxter International on 12 of the 16 factors compared between the two stocks.

How does Baxter International compare to Edwards Lifesciences?

Baxter International (NYSE:BAX) and Edwards Lifesciences (NYSE:EW) are both large-cap healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, analyst recommendations, earnings, valuation, profitability, dividends, media sentiment and institutional ownership.

Baxter International has a beta of 0.6, indicating that its share price is 40% less volatile than the broader market. Comparatively, Edwards Lifesciences has a beta of 0.85, indicating that its share price is 15% less volatile than the broader market.

90.2% of Baxter International shares are owned by institutional investors. Comparatively, 79.5% of Edwards Lifesciences shares are owned by institutional investors. 0.2% of Baxter International shares are owned by company insiders. Comparatively, 0.3% of Edwards Lifesciences shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Edwards Lifesciences has a net margin of 15.43% compared to Baxter International's net margin of -9.27%. Baxter International's return on equity of 16.57% beat Edwards Lifesciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Baxter International	-9.27%	16.57%	5.24%
Edwards Lifesciences	15.43%	15.68%	12.05%

Baxter International currently has a consensus target price of $22.45, indicating a potential downside of 18.24%. Edwards Lifesciences has a consensus target price of $100.27, indicating a potential upside of 11.85%. Given Edwards Lifesciences' stronger consensus rating and higher possible upside, analysts clearly believe Edwards Lifesciences is more favorable than Baxter International.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Baxter International	3 Sell rating(s)	8 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	1.92
Edwards Lifesciences	0 Sell rating(s)	6 Hold rating(s)	17 Buy rating(s)	0 Strong Buy rating(s)	2.74

In the previous week, Edwards Lifesciences had 1 more articles in the media than Baxter International. MarketBeat recorded 7 mentions for Edwards Lifesciences and 6 mentions for Baxter International. Edwards Lifesciences' average media sentiment score of 1.33 beat Baxter International's score of 0.49 indicating that Edwards Lifesciences is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Baxter International	2 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Edwards Lifesciences	5 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Edwards Lifesciences has lower revenue, but higher earnings than Baxter International. Baxter International is trading at a lower price-to-earnings ratio than Edwards Lifesciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Baxter International	$11.47B	1.24	-$957M	-$2.07	N/A
Edwards Lifesciences	$6.07B	8.51	$1.07B	$1.74	51.52

Summary

Edwards Lifesciences beats Baxter International on 13 of the 16 factors compared between the two stocks.

How does Baxter International compare to Becton, Dickinson and Company?

Becton, Dickinson and Company (NYSE:BDX) and Baxter International (NYSE:BAX) are both large-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, media sentiment, earnings, analyst recommendations, institutional ownership, risk, profitability and dividends.

Becton, Dickinson and Company presently has a consensus target price of $185.00, indicating a potential upside of 4.80%. Baxter International has a consensus target price of $22.45, indicating a potential downside of 18.24%. Given Becton, Dickinson and Company's stronger consensus rating and higher possible upside, equities analysts plainly believe Becton, Dickinson and Company is more favorable than Baxter International.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Becton, Dickinson and Company	1 Sell rating(s)	8 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.41
Baxter International	3 Sell rating(s)	8 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	1.92

Becton, Dickinson and Company has a beta of 0.19, indicating that its share price is 81% less volatile than the broader market. Comparatively, Baxter International has a beta of 0.6, indicating that its share price is 40% less volatile than the broader market.

87.0% of Becton, Dickinson and Company shares are owned by institutional investors. Comparatively, 90.2% of Baxter International shares are owned by institutional investors. 0.4% of Becton, Dickinson and Company shares are owned by insiders. Comparatively, 0.2% of Baxter International shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Becton, Dickinson and Company pays an annual dividend of $4.20 per share and has a dividend yield of 2.4%. Baxter International pays an annual dividend of $0.04 per share and has a dividend yield of 0.1%. Becton, Dickinson and Company pays out 126.5% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Baxter International pays out -1.9% of its earnings in the form of a dividend. Becton, Dickinson and Company has raised its dividend for 53 consecutive years. Becton, Dickinson and Company is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Becton, Dickinson and Company has higher revenue and earnings than Baxter International. Baxter International is trading at a lower price-to-earnings ratio than Becton, Dickinson and Company, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Becton, Dickinson and Company	$22.48B	2.16	$1.68B	$3.32	53.17
Baxter International	$11.47B	1.24	-$957M	-$2.07	N/A

Becton, Dickinson and Company has a net margin of 4.52% compared to Baxter International's net margin of -9.27%. Baxter International's return on equity of 16.57% beat Becton, Dickinson and Company's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Becton, Dickinson and Company	4.52%	14.84%	6.93%
Baxter International	-9.27%	16.57%	5.24%

In the previous week, Becton, Dickinson and Company had 26 more articles in the media than Baxter International. MarketBeat recorded 32 mentions for Becton, Dickinson and Company and 6 mentions for Baxter International. Becton, Dickinson and Company's average media sentiment score of 0.74 beat Baxter International's score of 0.49 indicating that Becton, Dickinson and Company is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Becton, Dickinson and Company	10 Very Positive mention(s)	2 Positive mention(s)	13 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Baxter International	2 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Becton, Dickinson and Company beats Baxter International on 15 of the 19 factors compared between the two stocks.

How does Baxter International compare to IDEXX Laboratories?

IDEXX Laboratories (NASDAQ:IDXX) and Baxter International (NYSE:BAX) are both large-cap healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, dividends, valuation, institutional ownership, earnings, media sentiment, profitability and risk.

IDEXX Laboratories has a net margin of 25.03% compared to Baxter International's net margin of -9.27%. IDEXX Laboratories' return on equity of 71.96% beat Baxter International's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
IDEXX Laboratories	25.03%	71.96%	33.60%
Baxter International	-9.27%	16.57%	5.24%

In the previous week, IDEXX Laboratories had 21 more articles in the media than Baxter International. MarketBeat recorded 27 mentions for IDEXX Laboratories and 6 mentions for Baxter International. IDEXX Laboratories' average media sentiment score of 0.95 beat Baxter International's score of 0.49 indicating that IDEXX Laboratories is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
IDEXX Laboratories	13 Very Positive mention(s)	3 Positive mention(s)	7 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Baxter International	2 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

IDEXX Laboratories has higher earnings, but lower revenue than Baxter International. Baxter International is trading at a lower price-to-earnings ratio than IDEXX Laboratories, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
IDEXX Laboratories	$4.30B	10.74	$1.06B	$14.22	41.26
Baxter International	$11.47B	1.24	-$957M	-$2.07	N/A

87.8% of IDEXX Laboratories shares are held by institutional investors. Comparatively, 90.2% of Baxter International shares are held by institutional investors. 0.8% of IDEXX Laboratories shares are held by insiders. Comparatively, 0.2% of Baxter International shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

IDEXX Laboratories presently has a consensus target price of $756.00, indicating a potential upside of 28.86%. Baxter International has a consensus target price of $22.45, indicating a potential downside of 18.24%. Given IDEXX Laboratories' stronger consensus rating and higher probable upside, equities research analysts clearly believe IDEXX Laboratories is more favorable than Baxter International.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
IDEXX Laboratories	0 Sell rating(s)	4 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.60
Baxter International	3 Sell rating(s)	8 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	1.92

IDEXX Laboratories has a beta of 1.54, indicating that its stock price is 54% more volatile than the broader market. Comparatively, Baxter International has a beta of 0.6, indicating that its stock price is 40% less volatile than the broader market.

Summary

IDEXX Laboratories beats Baxter International on 14 of the 16 factors compared between the two stocks.

Get Baxter International News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BAX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

BAX vs. The Competition

Export

Metric	Baxter International	Healthcare Equipment & Supplies Industry	Healthcare Sector	NYSE Exchange
Market Cap	$14.20B	$5.76B	$7.00B	$24.11B
Dividend Yield	0.15%	1.78%	2.58%	3.69%
P/E Ratio	-13.27	24.25	270.57	29.19
Price / Sales	1.24	68.34	659.56	13.03
Price / Cash	4.85	33.55	28.89	19.37
Price / Book	2.31	6.11	11.20	4.91
Net Income	-$957M	$149.01M	$3.45B	$1.06B
7 Day Performance	-1.97%	2.35%	3.39%	1.65%
1 Month Performance	21.33%	0.62%	-0.72%	2.63%
1 Year Performance	16.02%	4.91%	77.42%	20.40%

Baxter International Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
BAX Baxter International	1.2188 of 5 stars	$27.41 -0.5%	$22.45 -18.1%	+16.0%	$14.18B	$11.47B	N/A	37,500
AMN AMN Healthcare Services	2.9629 of 5 stars	$33.00 -1.9%	$29.00 -12.1%	+107.6%	$1.30B	$3.42B	N/A	2,664	News Coverage Earnings Report Analyst Forecast Gap Down
DVA DaVita	4.768 of 5 stars	$233.43 -2.8%	$216.50 -7.3%	+41.6%	$15.41B	$13.64B	21.65	78,000	Earnings Report Analyst Forecast High Trading Volume
EW Edwards Lifesciences	3.9135 of 5 stars	$88.75 +3.1%	$100.27 +13.0%	+14.4%	$49.56B	$6.07B	51.00	16,000	Positive News
BDX Becton, Dickinson and Company	3.9502 of 5 stars	$169.86 +2.6%	$180.93 +6.5%	-8.8%	$45.64B	$21.84B	43.00	72,000	Earnings Report Analyst Forecast

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:BAX) was last updated on 8/10/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Baxter International (BAX) Competitors

BAX vs. AMN, DVA, EW, BDX, and IDXX

How does Baxter International compare to AMN Healthcare Services?

Summary

How does Baxter International compare to DaVita?

Summary

How does Baxter International compare to Edwards Lifesciences?

Summary

How does Baxter International compare to Becton, Dickinson and Company?

Summary

How does Baxter International compare to IDEXX Laboratories?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

BAX vs. The Competition

Baxter International Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Baxter International (BAX) Competitors

BAX vs. AMN, DVA, EW, BDX, and IDXX

How does Baxter International compare to AMN Healthcare Services?

Is AMN or BAX more profitable?

Does the media favor AMN or BAX?

Which has higher earnings & valuation, AMN or BAX?

Which has more volatility & risk, AMN or BAX?

Do institutionals & insiders believe in AMN or BAX?

Is AMN or BAX a better dividend stock?

Do analysts prefer AMN or BAX?

Summary

How does Baxter International compare to DaVita?

Which has more volatility and risk, BAX or DVA?

Which has stronger valuation and earnings, BAX or DVA?

Do insiders and institutionals believe in BAX or DVA?

Is BAX or DVA more profitable?

Do analysts rate BAX or DVA?

Does the media refer more to BAX or DVA?

Summary

How does Baxter International compare to Edwards Lifesciences?

Which has more risk & volatility, BAX or EW?

Do institutionals and insiders believe in BAX or EW?

Is BAX or EW more profitable?

Do analysts prefer BAX or EW?

Does the media favor BAX or EW?

Which has higher valuation and earnings, BAX or EW?

Summary

How does Baxter International compare to Becton, Dickinson and Company?

Do analysts prefer BDX or BAX?

Which has more volatility & risk, BDX or BAX?

Do institutionals and insiders believe in BDX or BAX?

Is BDX or BAX a better dividend stock?

Which has higher earnings and valuation, BDX or BAX?

Is BDX or BAX more profitable?

Does the media favor BDX or BAX?

Summary

How does Baxter International compare to IDEXX Laboratories?

Is IDXX or BAX more profitable?

Does the media prefer IDXX or BAX?

Which has preferable earnings and valuation, IDXX or BAX?

Do institutionals & insiders believe in IDXX or BAX?

Do analysts recommend IDXX or BAX?

Which has more volatility and risk, IDXX or BAX?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

BAX vs. The Competition

Baxter International Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools